Hormone therapy for prostate cancer

Editor in Chief Marc B. Garnick, M.D.,* discusses the options and controversies

*Disclosure "" Dr. Garnick is currently serving as a consultant to SpecialtyEuropeanPharma, which is developing abarelix in Europe.

To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »